Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer
Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy consisting of
doxorubicin, cyclophosphamide, and docetaxel in treating women with stage IIIB or stage IV
breast cancer.